跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

AI Antibody Design vs Human Design: A Conceptual Overview

1Why Antibody Design Matters2How Humans Design Antibodies3How AI Learns to Design Antibodies4Comparing AI and Human Design5Evidence, Limits, and Open Questions
Evidence, Limits, and Open Questions

What the published comparisons actually show

1 / 4
The distinction that matters most here is between recovering known answers and producing new ones. In a retrospective study, the model is scored on antibodies that were already characterized, so a good result may only mean the test set looked like the training set. A prospective study is harder: the model proposes sequences nobody has made, and those sequences are then expressed and measured. That is the only design that supports a claim about real design ability, and it is also the design that is expensive and therefore rare. So when you read that an AI designed a working antibody, the first question is which of these two it was.
0:00 / 0:00

Two kinds of evidence, two different claims

Retrospective evaluation

  • Model is tested on antibodies already characterized in databases
  • Measures whether the model recovers known binders
  • Cheap, fast, and common
  • Cannot show that a genuinely new antibody would work

Prospective evaluation

  • Model proposes sequences that have never been made or tested
  • Those sequences are expressed and assayed in the lab
  • Expensive, slow, and less common
  • The only design that supports a real performance claim

AI-designed antibodies have been shown to bind their targets in real experiments, but the strongest claims rest on a small number of prospective studies. Most published comparisons are retrospective, and true head-to-head trials against human-designed antibodies on the same target are rare. The defensible statement is that AI design works for some targets, not that it outperforms human design in general.

A high success rate in a retrospective study is partly a measure of how well the test set resembles the training set. When the same databases supply both, strong scores can reflect memorization of familiar antibody families rather than general design ability.

上一页1 / 4下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion